FOR Dar es Salaam resident Frank Latamani, the chronic skin condition known as Psoriasis has become not only a painful ordeal ...

Surat: Slamming an insurance firm for rejecting a Covid-19 treatment claim by citing the patient's history of a skin disease, ...

With all that in mind, if you have $2,000 available to invest that isn't needed for monthly bills, to pay down short-term ...

Mr. Farbstein will present the latest developments in Can-Fite’s advanced stage drug development pipeline including the ...

A ONCE-RARE genital super-fungus that can only be killed off with a ‘toxic’ treatment is now spreading at pace among families ...

The model is accessible, where patients can attend appointments from home, work, or school, without sacrificing hours to ...

Namodenoson, a Phase III cancer drug has strong potential in veterinary oncology, a market projected to reach $3.1 billion by ...

CF602 is a novel A3AR allosteric modulator that enhances the receptor activity in the presence of the native ligand. The molecule is characterized by high selectivity at the A3AR and is capable of ...

Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven ...

For years, the company has sold everything from supplements to annuities to controversial health and finance advice. Will ...

Research has also shown that exposure to extreme temperatures, both hot and cold, can induce psychogenic fever and ...

Approval based on Phase 3 trials showing Dupixent significantly reduced itch and hives at 24 weeks compared to placebo In the EU, there are approximately 270,000 adults and adolescents aged 12 years ...